Skip to main content

Biolase, Inc

BIOLDelisted Sep 6, 2024
Industry
Dental Equipment & Supplies
SEC CIK
0000811240

Biolase, Inc was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 12, 2023; 29 institutions reported holding it in 13F filings for Q2 2023, worth $311.8K in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Biolase, Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of BIOL: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders251240
Shares1.39M401.48M+89.3K (+6.4%)
Value$6.34M$0$3.58M−$2.76M (−43.5%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (1)

Institutions that held Biolase, Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to BIOL in Q3 2022
InstitutionSharesValue% of portfolio
FMR LLC41$00.00%

Sold out (1)

Institutions that held Biolase, Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of BIOL in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
CoreCap Advisors, LLC44$0

Not filed for Q3 2022 yet (1)

Institutions that held Biolase, Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding BIOL in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Bivin & Associates, Inc.40$0